# CTEPH DIAGNOSIS Europe - MRI

Study · id `cardio:ct-nct02791282` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02791282](<https://clinicaltrials.gov/study/NCT02791282>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02791282

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1080 participants.

## Technical summary

Registry record NCT02791282. Allocation not applicable; no masking; primary purpose diagnostic. Start 2016-05 (registry gives no type); primary completion 2020-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Phase 3
- Enrolled: 1080 participants (planned count; ClinicalTrials.gov record NCT02791282, source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)
- Start date: 2016-05 (registry gives no type) (ClinicalTrials.gov record NCT02791282, source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)
- Primary completion: 2020-03 (anticipated) (ClinicalTrials.gov record NCT02791282, source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)
- Completion: 2020-06 (anticipated) (ClinicalTrials.gov record NCT02791282, source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)
- Countries: Germany (ClinicalTrials.gov record NCT02791282, source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02791282-2016-06-06`, retrieved 2026-10-31)

## The registry's words

- Brief title: CTEPH DIAGNOSIS Europe - MRI
- Condition: Pulmonary Hypertension
- Intervention (Other): Index test: functional dynamic contrast enhanced (DCE)-MRI
- Lead sponsor: Hannover Medical School
- Lead sponsor class: OTHER
- Collaborator: University of Sheffield
- Collaborator class: OTHER
- Collaborator: University of Giessen
- Collaborator class: OTHER
- Collaborator: Ludwig-Maximilians - University of Munich
- Collaborator class: OTHER
- Collaborator: Heidelberg University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Pulmonary hypertension (`cardio:pulmonary-hypertension`)
- Registry lists this organization as a collaborator: Ludwig-Maximilians - University of Munich (`cardio:org-ludwig-maximilians-university-of-munich`)

## Provenance

Content hash: be7f2363d78797ca965308812d756fa6e2cdf9cb178660f362183140c5f2ec7f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
